Numinus Wellness to Exit TSX April 22, Eyes CSE Listing Pending CTO Revocation
Numinus Wellness will be delisted from the Toronto Stock Exchange effective April 22, 2026, following a Continued Listing Committee determination consistent with shareholder authorization. The company has filed for a Canadian Securities Exchange listing pending cease trade order revocation and is completing its audited August 31, 2026 financial statements.
1. TSX Delisting Decision
On March 19, 2026, the Toronto Stock Exchange Continued Listing Committee determined to delist Numinus Wellness common shares effective April 22, 2026. This action aligns with the shareholder-approved authorization granted in August 2025, allowing the board to delist if deemed beneficial to the company’s strategic interests.
2. Trading Status and CTO
Numinus remains subject to a cease trade order, meaning its securities are currently not tradable in Canada. The impending TSX delisting will not change this status, and the company will continue as a reporting issuer in all applicable Canadian jurisdictions.
3. CSE Listing Application
Numinus has filed an application to list its common shares on the Canadian Securities Exchange, contingent upon the CTO being revoked. Approval will depend on the company meeting the CSE’s listing requirements, which remain uncertain until regulatory conditions are satisfied.
4. Management's Next Steps
Management is focused on completing the audit for the year ended August 31, 2026, satisfying all regulatory requirements to have the CTO revoked, and advancing the CSE listing application. Successfully executing these steps is central to restoring trading, enhancing shareholder liquidity, and positioning the company for growth.